HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HBW Executive Decisions: Perrigo CFO Joins Neptune Wellness, Athletes Promote Wellness Products, More

Executive Summary

Perrigo CFO has 10-dy break before starting at Neptune Wellness ; CHPA board elects Lisa Paley as chair, Ian Thorpe joins Anthogenol team; Shreyas Iyer advertises Ultrahuman wearable; HRG expands business sectors with Corey Paske; and DFE Pharma hires Marie-Louise Mans as HR director. 

You may also be interested in...



Silcock’s Work As Perrigo CFO Is Done With Firm Transitioned Entirely To Self-Care

With Raymond Silcock’s work at Perrigo linked to CEO Murray Kessler’s time with the firm and with the two working together previously as CFO and CEO at a tobacco firm, whether Kessler continues at the helm could become a topic of shareholder interest.

HBW US Roundup: Product Launches, ChromaDex, Mannatech, MusclePharm, USANA Results

Product launches by Power Life Nutrition, PlantFuel Life, Cymbiotik and JSHealth; third-quarter sales up for ChromaDex and Mannatech, slip for MusclePharm and USANA.

USPSTF Doesn’t See Forest Of VMS Benefits For Trees Of Reducing Cancer, Heart Disease Risks

US Preventative Services Task Force concludes evidence doesn't support  recommending VMS use to prevent cancer or cardiovascular disease. Trade groups and a natural medicine expert say task force's focus is narrow and its recommendation misleading. 

Topics

Related Companies

Latest News
UsernamePublicRestriction

Register

RS152642

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel